Insurance benefits of Glivec available for all CML patients

Published: 2003-03-03 06:58:00

Updated: 2003-03-03 06:58:00

The Korea Food and Drug Administration (KFDA) said on February 26 that it modified the conventional indications and dosage & administration of Glivec capsule, antileukemia drug, based on that of Novartis in Switzerland and thus Glivec insurance can cover even chronic myelongenous leukemia (CML) p...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK